Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nolwenn Juhel
Observed name:
N. Juhel
Institution:
Boehringer Ingelheim (France)
Observed institution:
Boehringer Ingelheim (France)
OpenAlex ID:
A5072003755
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
2011
·
Luca Richeldi
, Ulrich Costabel
, et al.
·
New England Journal of Medicine
·
1,248
PDF
Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
2011
·
A.H.V. Schapira
, P. Barone
, et al.
·
Neurology
·
119
Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
2010
·
Robert A. Hauser
, Anthony H.V. Schapira
, et al.
·
Movement Disorders
·
108
Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial
2011
·
W. Poewe
, O. Rascol
, et al.
·
Neurology
·
105
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease
2006
·
Robert A. Hauser
, Laurence Salin
, et al.
·
Movement Disorders
·
52
Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations: The ADVANS Study
2008
·
Olivier Rascol
, Werner Poewe
, et al.
·
Archives of Neurology
·
36
The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study
2014
·
Ying Wang
, Shenggang Sun
, et al.
·
Translational Neurodegeneration
·
20
PDF
Phase I trial of volasertib (BI 6727), a polo-like kinase 1 (Plk1) inhibitor, in combination with cisplatin or carboplatin in patients with advanced solid tumors.
2011
·
A. Deleporte
, H. Dumez
, et al.
·
Journal of Clinical Oncology
·
5
PDF
The Oral Triple Kinase Inhibitor BIBF 1120 Reduces Decline In Lung Function In Patients With Idiopathic Pulmonary Fibrosis (IPF): Results From The Tomorrow Study
2011
·
Luca Richeldi
, Kevin K. Brown
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease
2009
·
A. Schapira
, P. Barone
, et al.
·
Parkinsonism & Related Disorders
·
1
Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial
2011
·
Ulrich Costabel
, Luca Richeldi
, et al.
·
European Respiratory Journal
Effect of baseline FVC on preservation of lung function with BIBF 1120: Results from the TOMORROW trial
2011
·
Luca Richeldi
, Ulrich Costabel
, et al.
·
European Respiratory Journal
Treatment With BIBF 1120 Reduces Acute Exacerbations And Improves Quality Of Life In Patients With IPF: Results From The Tomorrow Study
2011
·
Luca Richeldi
, Kevin K. Brown
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease
2009
·
W. Poewe
, P. Barone
, et al.
·
Parkinsonism & Related Disorders
Show more works
View as search
Works count:
14
Citation count:
1,696
H-index:
7
I10-index:
7
Year
Topic
Type